A RANDOMIZED PROSPECTIVE DOUBLE BLIND STUDY TO EVALUATE THE COMPARATIVE EFFICACY OF THREE DIFFERENT HAIR OIL FORMULATIONSH0/701, HO/702 AND HO/703IN HEALTHY ADULT FEMALE SUBJECTS -

Dabur India Limited0 个研究点目标入组 72 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•a.Female subjects aged 18 to 35 years and capable of providing written informed consent. With complaint of mild to moderate dandruff and hair fall
•b.Female subjects with at least shoulder length hair.
•c.Regular (at least twice a week) user of a commercially available brand of hair oil and shampoo.
•d.The female subject should be a healthy individual.
•e.The female subject should be considered as reliable and capable of adhering to the protocol, according to the judgment of the Investigator.

•a.Pre-existing hair disease or scalp disease other than Hair fall (with no obvious underlying illness).
•b.Concomitant medications or treatments affecting the hair (e.g.: Minoxidil application,
•Chemotherapy)
•c.A positive urine pregnancy test
•d.Subjects not willing to provide informed consent.
•e.Use of styling tools,hair dyes,perms etc.
•f.Excessive exposure to sun,chemicals in pools (not more than once in a week), or salt in oceans .
•g.Pregnant, lactating or sexually active women with childbearing potential who are not
•using a medically accepted birth control method.
•h.History or presence of cardiovascular , respiratory, hepatic, renal, gastrointestinal ,
•endocrinological , neurological disorders.
•i. History or presence of drug addiction.
•j.History of frequent and severe headache.
•k.Subjects who are known to have serum hepatitis, or who are carriers of the Hepatitis B surface antigen (Hbs-Ag),or Hepatitis C antibody or who are HIV positive.
•I. Participation in another clinical trial in less than 12 weeks before the screening visit. m.Known allergy I intolerance to the investigational product.
•n.Any clinical conditions that in the opinion of the Investigator would make the subject unsuitable for the trial.

发起方